Atomistry » Fluorine » PDB 8uq7-8v81 » 8ute
Atomistry »
  Fluorine »
    PDB 8uq7-8v81 »
      8ute »

Fluorine in PDB 8ute: Structure of Sars-COV2 3CLPRO in Complex with Compound 27

Enzymatic activity of Structure of Sars-COV2 3CLPRO in Complex with Compound 27

All present enzymatic activity of Structure of Sars-COV2 3CLPRO in Complex with Compound 27:
3.4.22.69;

Protein crystallography data

The structure of Structure of Sars-COV2 3CLPRO in Complex with Compound 27, PDB code: 8ute was solved by H.Krishnamurthy, N.Zhuang, D.Qiang, Y.Wu, D.J.Klein, with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:

Resolution Low / High (Å) 44.55 / 1.45
Space group C 1 2 1
Cell size a, b, c (Å), α, β, γ (°) 94.82, 80.21, 54.11, 90, 116.37, 90
R / Rfree (%) 20.3 / 22.5

Fluorine Binding Sites:

The binding sites of Fluorine atom in the Structure of Sars-COV2 3CLPRO in Complex with Compound 27 (pdb code 8ute). This binding sites where shown within 5.0 Angstroms radius around Fluorine atom.
In total 2 binding sites of Fluorine where determined in the Structure of Sars-COV2 3CLPRO in Complex with Compound 27, PDB code: 8ute:
Jump to Fluorine binding site number: 1; 2;

Fluorine binding site 1 out of 2 in 8ute

Go back to Fluorine Binding Sites List in 8ute
Fluorine binding site 1 out of 2 in the Structure of Sars-COV2 3CLPRO in Complex with Compound 27


Mono view


Stereo pair view

A full contact list of Fluorine with other atoms in the F binding site number 1 of Structure of Sars-COV2 3CLPRO in Complex with Compound 27 within 5.0Å range:
probe atom residue distance (Å) B Occ
A:F501

b:21.5
occ:1.00
F1 A:XKQ501 0.0 21.5 1.0
C19 A:XKQ501 1.4 21.8 1.0
F A:XKQ501 2.2 23.1 1.0
C18 A:XKQ501 2.3 20.2 1.0
C20 A:XKQ501 2.4 21.5 1.0
H30 A:XKQ501 2.5 20.2 0.0
H27 A:XKQ501 2.6 20.5 0.0
H32 A:XKQ501 2.6 21.5 0.0
H31 A:XKQ501 2.6 21.5 0.0
C17 A:XKQ501 3.0 20.5 1.0
NE2 A:HIS163 3.0 17.4 1.0
H29 A:XKQ501 3.3 20.2 0.0
H33 A:XKQ501 3.3 21.5 0.0
CB A:GLU166 3.4 18.7 1.0
H28 A:XKQ501 3.5 20.5 0.0
N A:GLU166 3.6 18.0 1.0
C A:MET165 3.7 17.9 0.5
C A:MET165 3.7 18.1 0.5
CE1 A:HIS163 3.8 17.4 1.0
CA A:GLU166 4.0 17.9 1.0
O A:MET165 4.1 17.9 0.5
CA A:MET165 4.1 17.2 0.5
CA A:MET165 4.1 17.6 0.5
CD2 A:HIS163 4.1 16.6 1.0
O A:MET165 4.1 18.1 0.5
CD2 A:HIS172 4.2 18.7 1.0
H26 A:XKQ501 4.2 22.7 0.0
OE2 A:GLU166 4.2 18.9 1.0
CB A:PHE140 4.3 17.9 1.0
C16 A:XKQ501 4.3 21.7 1.0
N2 A:XKQ501 4.4 22.7 1.0
H13 A:XKQ501 4.4 24.1 0.0
O A:XKQ501 4.4 22.9 1.0
O A:PHE140 4.5 19.9 1.0
NE2 A:HIS172 4.6 19.5 1.0
CG A:GLU166 4.6 19.2 1.0
N A:MET165 4.6 16.8 0.5
N A:MET165 4.6 16.6 0.5
OG A:SER144 4.7 20.2 1.0
H4 A:XKQ501 4.8 21.7 0.0
CD A:GLU166 4.8 21.7 1.0
C A:PHE140 4.9 19.0 1.0
ND1 A:HIS163 5.0 15.9 1.0

Fluorine binding site 2 out of 2 in 8ute

Go back to Fluorine Binding Sites List in 8ute
Fluorine binding site 2 out of 2 in the Structure of Sars-COV2 3CLPRO in Complex with Compound 27


Mono view


Stereo pair view

A full contact list of Fluorine with other atoms in the F binding site number 2 of Structure of Sars-COV2 3CLPRO in Complex with Compound 27 within 5.0Å range:
probe atom residue distance (Å) B Occ
A:F501

b:23.1
occ:1.00
F A:XKQ501 0.0 23.1 1.0
C19 A:XKQ501 1.3 21.8 1.0
F1 A:XKQ501 2.2 21.5 1.0
C18 A:XKQ501 2.3 20.2 1.0
C20 A:XKQ501 2.4 21.5 1.0
H28 A:XKQ501 2.6 20.5 0.0
H31 A:XKQ501 2.6 21.5 0.0
H29 A:XKQ501 2.7 20.2 0.0
H33 A:XKQ501 2.7 21.5 0.0
C17 A:XKQ501 2.8 20.5 1.0
H27 A:XKQ501 2.9 20.5 0.0
O A:LEU141 2.9 20.8 1.0
C A:LEU141 3.0 21.6 1.0
OG A:SER144 3.2 20.2 1.0
H30 A:XKQ501 3.2 20.2 0.0
H32 A:XKQ501 3.3 21.5 0.0
O A:PHE140 3.5 19.9 1.0
N A:ASN142 3.6 22.4 1.0
C A:PHE140 3.6 19.0 1.0
N A:LEU141 3.7 20.2 1.0
CB A:PHE140 3.7 17.9 1.0
CA A:LEU141 3.7 21.2 1.0
NE2 A:HIS163 3.7 17.4 1.0
CA A:ASN142 4.0 23.1 1.0
CD2 A:HIS163 4.3 16.6 1.0
C16 A:XKQ501 4.3 21.7 1.0
CA A:PHE140 4.3 17.8 1.0
CB A:SER144 4.5 18.6 1.0
H4 A:XKQ501 4.5 21.7 0.0
O4 A:XKQ501 4.7 23.0 1.0
CG A:PHE140 4.8 17.8 1.0
N A:SER144 4.8 20.5 1.0
CE1 A:HIS163 4.9 17.4 1.0
C A:ASN142 4.9 22.9 1.0

Reference:

V.W.Shurtleff, M.E.Layton, C.A.Parish, J.J.Perkins, J.D.Schreier, Y.Wang, G.C.Adam, N.Alvarez, S.Bahmanjah, C.M.Bahnck-Teets, C.W.Boyce, C.Burlein, T.D.Cabalu, B.T.Campbell, S.S.Carroll, W.Chang, M.De Lera Ruiz, E.Dolgov, J.F.Fay, N.G.Fox, S.L.Goh, T.J.Hartingh, D.M.Hurzy, M.J.Kelly 3Rd, D.J.Klein, F.M.Klingler, H.Krishnamurthy, S.Kudalkar, T.W.Mayhood, P.M.Mckenna, E.M.Murray, D.Nahas, C.C.Nawrat, S.Park, D.Qian, A.J.Roecker, V.Sharma, W.D.Shipe, J.Su, R.V.Taggart, Q.Truong, Y.Wu, X.Zhou, N.Zhuang, D.S.Perlin, D.B.Olsen, J.A.Howe, J.A.Mccauley. Invention of Mk-7845, A Sars-Cov-2 3CL Protease Inhibitor Employing A Novel Difluorinated Glutamine Mimic. J.Med.Chem. 2024.
ISSN: ISSN 0022-2623
PubMed: 38365209
DOI: 10.1021/ACS.JMEDCHEM.3C02248
Page generated: Wed Jul 16 09:25:27 2025

Last articles

Fe in 2YXO
Fe in 2YRS
Fe in 2YXC
Fe in 2YNM
Fe in 2YVJ
Fe in 2YP1
Fe in 2YU2
Fe in 2YU1
Fe in 2YQB
Fe in 2YOO
© Copyright 2008-2020 by atomistry.com
Home   |    Site Map   |    Copyright   |    Contact us   |    Privacy